Thank you for joining us for the Founder-Led Biotech Summit, where we spotlighted and supported founder-led biotech companies. Below are the recorded sessions from the events.
Welcome & KEYNOTE WITH EMILY LEPROUST
Emily Leproust is an American scientist and entrepreneur. She is the CEO and co-founder of Twist Bioscience, a public company working on DNA synthesis.
Co-founder & CEO, Twist Bioscience
Sri is a biologist that has built technologies, labs, and companies in synthetic biology, functional genomics, and bioinformatics over the last 20 years. He is currently co-founder and CEO of Octant.
Co-founder & CEO, Octant
Data Platforms in Biotech
We discuss the sweeping transformation of biotech’s data platforms and how it is enabling new kinds of life science.
Co-founder & CEO, Latch Bio
Co-founder & CEO, Lamin Labs
CTO, Omega Funds
Chris has led Recursion as CEO since founding through public listing, 4 clinical-stage programs, and over 50 pre-clinical and discovery programs in diverse therapeutic areas.
Co-founder & CEO, Recursion
Josh has held key business development and operations leadership roles at leading biotech companies over the past 20 years. He is currently CEO at Camp4 which raised a $100M Series B this summer.
CEO, Camp4 Therapeutics
Pathways to Entrepreneurship
Three entrepreneurs of different backgrounds tell us how they got where they are, and advice for starting companies.
Co-founder & CEO, Octagon Therapeutics
Co-founder & CPO, Stealth
Co-founder & CTO, Gate Bioscience
The future of reproduction will look very different than today. Join us with four founders working on different problems in this exciting space.
CEO and Co-founder, Vitra Labs
Founder and CEO, Celmatix
Co-founder & CEO, Contraline
Andy is the co-founder and CEO of PathAI whose mission is to improve patient outcomes with AI-powered pathology.
Co-founder & CEO, PathAI
Seemay is trained as a biochemist/structural biologist with Tom Alber at UC Berkeley and is interested in uncovering mechanisms that drive microbe-microbe and host-microbe interactions.
Co-founder & CEO, Arcadia Science
Alec is founder & CEO of Asimov where they are developing a mammalian synthetic biology platform––from cells to software––to enable biotechnologies with outsized impact.
Founder & CEO, Asmiov
Bioengineering for Therapeutics
Gene and cell therapies are reshaping how we address previously untreatable illnesses. Join us for a panel with four founders leading the industry.
Co-founder & CEO, Cartography
Co-founder & CEO, 64x Bio
Founder & CEO, Amber Bio
Co-founder & CEO, Strand Therapeutics
Next-generation Tools for Life Sciences
Sydney Brenner once said “Progress in science depends on new techniques, new discoveries and new ideas, probably in that order.” Visions for where tools will take us.
Co-founder & CEO, Stealth
Co-founder & CEO, Portal Biotech
Founder & CEO, Matterworks
Co-founder & CTO, Day Zero Diagnostics
Sustainability and Climate Biotech
Four founders tell us about new applications for biotechnology to build a more climate-positive future.
Co-founder & CEO, Galy
Co-founder & CEO, Tezza
Founder & CEO, Compound
Co-founder & CEO, Modern Synthesis
New Funding and Organizational Models
We explore the recent explosion of new models for biotech innovation.
Founder & CEO, Vibe Bio
Co-founder & COO, Convergent Research
Director, Impetus Grants
Jasmin founded the biotechnology startup Shiru to make delicious, nutritious, sustainable, and scalable ingredients so that all food companies on Earth can quickly develop plant-based products.
Founder & CEO, Shiru